Stanford researchers look at PTZ

as a possible link in understanding memory and cognition in people with Down syndrome.

Stanford researchers believe that “PTZ and the other compounds may work because they block a neurotransmitter that slows brain function. That neurotransmitter is believed to work too well in Down syndrome patients, hampering learning and memory,” according to a news story in today’s San Jose Mercury News.


3 thoughts on “Stanford researchers look at PTZ

  1. It’s Pandora’s box, isn’t it? You won’t know what you get until you try it. And I imagine there will be anticipated benefits, as well as unexpected costs. I really don’t know how I feel about this, either.

  2. I just wrote an article about this for Strollerderby, due to be published tomorrow. I’m truly torn about this. Yes I want everything for my child, but at what price? How would PTZ really change people? Is anyone here ready to jump on the bandwagon, assuming the drug is hypothetically approved for use, say, tomorrow?

    On the one hand I find this tremendously exciting, and on the other, totally scary.

    What do you all think?

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s